Microflow cytometers, combining microfluidics and miniaturized detection systems, are a promising solution for future diagnosis.
During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the flow cytometry markets worldwide.
The designs of instruments and processing techniques are evolving to meet the needs of researchers and drug developers. The aim is to allow faster, more accurate experiments.
Routine clinical applications of flow cytometry have begun to increase in number and complexity, driven largely by advances in technology.
The flow-cytometry market globally remains one of the fastest growing segments of life sciences and clinical diagnostics markets and yet India faced a stagnant market in 2014-15.